Avidity Partners Management’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
Other funds holding ACIU
BI
RG
PIM
Avidity Partners Management's ACIU Position: Q3 2024 in Review
Avidity Partners Management sold out of AC Immune (ACIU) in Q3 2024, closing a stake of 825,000 shares — an estimated $3.29M sold.
Avidity Partners Management first reported a position in ACIU in Q3 2020 and held it in 11 quarters. The position peaked at $22.3M in Q4 2023. 43 funds tracked by Wall St. Rank hold ACIU as of Q3 2024.
- Avidity Partners Management reported no remaining AC Immune position as of Q3 2024 after selling out during the quarter.
- Avidity Partners Management sold 825,000 AC Immune shares in Q3 2024, an estimated $3.29M.
- Avidity Partners Management first reported a position in AC Immune in Q3 2020 and held it in 11 quarters.
- Avidity Partners Management's AC Immune position peaked at $22.3M in Q4 2023.
- 43 funds tracked by Wall St. Rank held AC Immune as of Q3 2024.
Based on Avidity Partners Management's 13F filing for Q3 2024, filed 14 Nov 2024.